Finance and Investment

Key partners convert debt to equity at a premium, demonstrating confidence in DevvStream’s long-term value CALGARY, Alberta — DevvStream Corp. (NASDAQ: DEVS) (“DevvStream” or the “Company”), a leading carbon management and environmental asset development company, today announced a series of strategic transactions that collectively reduce approximately $5.9 million of outstanding debt, materially strengthening the Company’s

UBS Asset Management is betting the market has gotten too far ahead of itself positioning for interest-rate hikes by the Bank of England and the European Central Bank.

OPEC’s crude oil production climbed last month as group leader Saudi Arabia bolstered production amid rising regional tensions, a Bloomberg survey showed.

As OBSI assumes expanded mandate as the ombudsman for all of Canada’s banks, consumer demand reaches new highs TORONTO, March 13, 2026 (GLOBE NEWSWIRE) — The Ombudsman for Banking Services and Investments (OBSI) released its 2025 Annual Report. In 2025, OBSI began serving as the single external complaints body (ECB) for all of Canada’s banks,

SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2025 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue of Junshi Biosciences was

Some Western automakers have stepped up efforts to tap Chinese carmakers for assistance and production capacity

Rory Johnston: IEA oil reserve release still not enough to offset Strait of Hormuz shut down

$8.6 billion project financing for CP2 Phase 2 brings project’s total financing to $20.7 billion Project expected to make Venture Global the largest exporter of US LNG Unprecedented milestone of five FIDs in less than 7 years, with over $95 billion in capital markets transactions ARLINGTON, Va. — Today, Venture Global, Inc. (NYSE: VG) is

– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA treatment demonstrates a meaningful and statistically significant improvement over robotic RP in the preservation of erectile function together with continence at 6 months – TORONTO, March